Family · Pharmaceutical analytical standards
Tazobactam
An inhibitor of beta-lactamases, the enzymes bacteria use to destroy penicillins and cephalosporins. Patented in 1982 and in use since 1992, it is paired with piperacillin and ceftolozane to protect them and broaden their spectrum. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?On its own it has very little antibacterial activity: it acts as a 'bodyguard', binding irreversibly to bacterial enzymes and disabling them before they can attack the antibiotic.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
